Advertisement
Smith & Nephew plc

Smith & Nephew plc (SNN) Stock Overview

Explore Smith & Nephew plc’s financial performance, market position, analyst ratings, and future outlook.

SNNNYSE
HealthcareMedical - Devices
$30.04
$0.18(0.60%)
U.S. Market opens in 54h 48m
Advertisement

Smith & Nephew plc (SNN)

Meyka AI Score

Z

Key Financials

Market Cap12.7B
P/E Ratio20.49
EPS (TTM)$1.85
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$30.52
3 Months$37.68
1 Year Target$38.61

SNN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Smith & Nephew plc (SNN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $38.61.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.49 and a market capitalization of 12.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.65%
5-Day Change
0.38%
1-Month Change
-1.33%
3-Month Change
-6.96%
6-Month Change
-9.13%
Year-to-Date (YTD) Change
-8.49%
1-Year Change
-0.61%
3-Year Change
-4.47%
5-Year Change
-30.71%
All-Time (Max) Change
263.94%

Contact Information

44 1923 477 100
Building 5 Croxley Park Hatters Lane, Watford, HRT, WD18 8YE

Company Facts

178,180 Employees
IPO DateNov 16, 1999
CountryGB
Actively Trading

Frequently Asked Questions